Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

The Utility of Vitamin K3 (Menadione) against Pancreatic Cancer

SHINJI OSADA, HIROYUKI TOMITA, YOSHIHIRO TANAKA, YASUHARU TOKUYAMA, HIDENORI TANAKA, FUMIO SAKASHITA and TAKAO TAKAHASHI
Anticancer Research January 2008, 28 (1A) 45-50;
SHINJI OSADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sting@gifu-u.ac.jp
HIROYUKI TOMITA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIRO TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHARU TOKUYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDENORI TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIO SAKASHITA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAO TAKAHASHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: To evaluate the efficacy of vitamin K3 (VK3) against pancreatic cancer, the molecular mechanism of VK3 or gemcitabine (GEM)-induced inhibition of proliferation was characterized. Materials and Methods: The cell viability was determined using the 3-[4,5-dimethylthiazol]-2,5-diphenyl tetrazolium bromide (MTT) test method. The expressions of cellular proteins were evaluated by Western blot analysis. For morphological studies of the in vivo transplanted cancer cells, the tissues were stained with hematoxylin and eosin. Results: The IC50 of VK3 for pancreatic cancer cells was calculated for 42.1±3.5 μM. Western blot analysis showed that VK3 induced rapid phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) 30 minutes after application. ERK but not JNK phosphorylation was maintained for at least 12 hours. Activation of apoptosis by VK3, as shown by molecular weight shifts of the pro-activated 32-kDa form of caspase-3 and poly(ADP-ribose)polymerase (PARP) cleavage of the 112-kDa form, was found. Treatment with the thiol antioxidant, L-cysteine (>0.2 mM), completely abrogated the VK3-induced phosphorylation of ERK, but not the JNK, and inhibition of proliferation. A caspase-3 inhibitor antagonized caspase-3 activation, but had no inhibitory effect on the proliferative activity of VK3. GEM at concentrations >0.1 μg/ml was found to inhibit cell proliferation after 24 hours. GEM also induced phosphorylation of JNK, activation of caspase-3 and accumulation of cyclin B1. Local application of VK3 was found to induce extensive tumor tissue necrosis, but slight hematemesis without necrosis was observed 48 hours after GEM injection. In Western blot, ERK, but not JNK phosphorylation, was clearly detected in response to VK3 injection into the tumor tissue. Conclusion: The action of VK3 may lead to a favorable outcome against pancreatic cancer, and the detection of ERK phosphorylation in the tissue is important for predicting this effect.

  • Pancreatic cancer
  • vitamin K3 (menadione)
  • chemotherapy
  • endoscopic ultrasound-guided fine needle injection
  • drug delivery system
  • Received July 30, 2007.
  • Revision received October 2, 2007.
  • Accepted October 26, 2007.
  • Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 28 (1A)
Anticancer Research
Vol. 28, Issue 1A
January-February 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Utility of Vitamin K3 (Menadione) against Pancreatic Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Utility of Vitamin K3 (Menadione) against Pancreatic Cancer
SHINJI OSADA, HIROYUKI TOMITA, YOSHIHIRO TANAKA, YASUHARU TOKUYAMA, HIDENORI TANAKA, FUMIO SAKASHITA, TAKAO TAKAHASHI
Anticancer Research Jan 2008, 28 (1A) 45-50;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Utility of Vitamin K3 (Menadione) against Pancreatic Cancer
SHINJI OSADA, HIROYUKI TOMITA, YOSHIHIRO TANAKA, YASUHARU TOKUYAMA, HIDENORI TANAKA, FUMIO SAKASHITA, TAKAO TAKAHASHI
Anticancer Research Jan 2008, 28 (1A) 45-50;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Menadione reduces the expression of virulence- and colonisation-associated genes in Helicobacter pylori
  • The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer
  • Vitamins in Pancreatic Cancer: A Review of Underlying Mechanisms and Future Applications
  • Combination Therapy of 5-Fluorouracil with Rapamycin for Hormone Receptor-negative Human Breast Cancer
  • Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?
  • Google Scholar

More in this TOC Section

  • Predictive Factors for Multiple Metastases of Clear-cell Renal Cell Carcinoma
  • Acyclic Retinoid Overcomes Vemurafenib Resistance in Melanoma Cells via Dual Inhibition of MAPK and PI3K/AKT/mTOR Pathways
  • Tumor Immunology Visualized in Realtime in In-vivo-like 3-D Gelfoam® Histoculture by Color-coded Imaging
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire